Join CBSET's partner, CILcare, who is organizing and sponsoring the 2nd Inner Ear Disorders Therapeutics Summit event in Boston, MA, June 20-23, 2022.
The 2nd Inner Ear Disorders Therapeutics Summit will unite drug developers focusing on preventative and regenerative approaches targeting the inner ear. This 4-day disease-agnostic, modality-agnostic event designed specifically for industry-based experts in inner ear disorders to successfully translate their therapeutics into the clinic.
Mathieu SCHUE, PhD, Project Director for Drug Development and Translational Research at CILcare, will be speaking at this event on: Sensorineural hearing Loss as a comorbidity of chronic inflammatory diseases.
Related CBSET Services:
Related CBSET & CILcare Publications:
- Intracochlear Drug Delivery Systems: A Novel Approach Whose Time Has Come. Peppi M, Marie A, Belline C, Borenstein JT. Expert Opinion in Drug Delivery. 2018 Feb 26. doi: 10.1080/17425247.2018.1444026.
by Michael Naimark, Director of Business Development, CBSET, Inc. and Marie-Pierre Pasdelou, PharmD, founder and the Chief Development Officer, CILcare
World Pharma Today: Stem Cell and Regenerative Therapies for Hearing Loss
by Michael Naimark, Director of Business Development, CBSET, Inc. and Marie-Pierre Pasdelou, PharmD, founder and the Chief Development Officer, CILcare